Get Premium to unlock powerful stock data
NAS:MRNA (USA)  
Moderna Inc logo

Moderna Inc

$ 144.27 +1.01 (+0.71%) 08:08 PM EST
P/E:
4.31
P/B:
3.44
Market Cap:
$ 57.38B
Enterprise V:
$ 47.82B
Volume:
7.25M
Avg Vol (2M):
6.25M
Also Trade In:
Volume:
7.25M
Market Cap $:
57.38B
PE Ratio:
4.31
Avg Vol (2-Month):
6.25M
Enterprise Value $:
47.82B
PB Ratio:
3.44
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 10.68
Equity-to-Asset 0.62
Debt-to-Equity 0.06
Debt-to-EBITDA 0.06
Interest Coverage 774.14
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.01
Distress
Grey
Safe
Beneish M-Score 6.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 71.01
9-Day RSI 60.08
14-Day RSI 55.09
6-1 Month Momentum % -47.17
12-1 Month Momentum % -40.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.77
Quick Ratio 1.56
Cash Ratio 1.09
Days Inventory 116.36
Days Sales Outstanding 47.58
Days Payable 14.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-08-05 Est.)

MRNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MRNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 22,600
EPS (TTM) ($) 34.03
Beta 1.57
Volatility % 81.62
14-Day RSI 55.09
14-Day ATR ($) 9.91963
20-Day SMA ($) 135.0525
12-1 Month Momentum % -40.01
52-Week Range ($) 115.61 - 497.49
Shares Outstanding (Mil) 397.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Moderna Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More